GRACE QARMOUT: Open Payments
NPI 1487905246 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 10 payments from 6 companies in 2025. Trend: 2023 $138 · 2024 $162 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $177 |
| Lilly USA, LLC | 1 | $114 |
| Exeltis, USA Inc. | 2 | $36 |
| OptumHealth Care Solutions, LLC | 1 | $18 |
| MILLICENT US INC | 1 | $17 |
| Organon LLC | 1 | $15 |
Products named: Veozah, MOUNJARO, SLYND, VIVIFY HEALTH CARE TEAM PORTAL 001, FEMRING, NEXPLANON.
Industry payments across NJ — which companies pay providers there.
